Synopsis: Elitecon International plans to invest Rs. 700 crore to expand its FMCG business, targeting Rs. 20,000 crore in revenue by FY30, backed by strong export orders.
This Small-Cap Tobacco Stock, engaged in manufacturing and exporting tobacco products while expanding into FMCG segments such as packaged foods, snacks, edible oils, and household essentials, hit a 20 percent upper circuit after plans to invest Rs. 700 crore to expand its FMCG business.
With a market capitalization of Rs. 5,164.75 crores, the shares of Elitecon International Limited hit a 20 percent upper circuit of Rs. 32.46 per share on Wednesday, up from its previous closing price of Rs. 27.05 per share. Since then, the stock has retreated and is currently trading at Rs. 32.31 per equity share.
Reason Behind the Surge
Elitecon International has unveiled an ambitious roadmap to build a diversified FMCG business and achieve revenue of approximately Rs. 20,000 crore by FY30. To support this vision, the company has outlined an indicative capital investment of Rs. 700 crore, which will be deployed in phases across packaged foods, snacks, edible oils, and household essentials. The expansion will leverage its existing 40,000+ sq. ft. manufacturing facility in Nashik, Maharashtra, along with future capacity enhancements.
The company’s growth plans are supported by a strong international tobacco export business. Elitecon currently holds a contracted tobacco order book worth over USD 119 million across Africa and the Middle East. This includes a two-year export agreement with South Africa-based Bozza Tobacco valued at approximately Rs. 202 crore and an ongoing USD 97.35 million export order being executed through Yuvi International Trade FZE for the Middle East market.
Under its FMCG expansion strategy, Elitecon aims to build a distribution network of 5,000 partners, establish a presence across more than 5 lakh retail outlets, and expand into over 15 international markets. The company also plans to develop a portfolio of 10 consumer brands and more than 150 SKUs, creating a diversified platform for long-term growth.
With a combination of strong export orders, planned investments, manufacturing capabilities, and an expanding product portfolio, Elitecon is positioning itself to become a significant player in the FMCG sector while targeting substantial revenue growth over the next few years.
Management Commentary
Kumar Anubhav Upadhyay, Executive Director, Elitecon International Limited, said that “Our focus today is on disciplined execution of milestones we have already disclosed. An USD 119 Million-plus international order book across Africa and the Middle East, a 40,000+ sq. ft. manufacturing engine at Nashik, and a clearly articulated FY30 FMCG ambition together give Elitecon a credible multi-year growth corridor.
Our task is to convert that direction into capacity utilised, distributors onboarded, SKUs shipped and customers served. We will continue to update the market through formal disclosures as each milestone is achieved, and we will sequence every FMCG launch strictly behind documented readiness rather than against arbitrary timelines.”
Company Overview
Elitecon International Limited is an Indian manufacturing, export, and FMCG company, listed on the Bombay Stock Exchange and rooted in the tobacco and fast-moving consumer goods sectors. Formerly known as Kashiram Jain & Company Limited, it has evolved from a legacy trading business into a diversified consumer-focused enterprise with a growing global footprint.
Recent Quarter Results
Coming into financial highlights, Elitecon International Limited’s revenue has increased from Rs. 94 crore in Q3 FY25 to Rs. 1,741 crore in Q3 FY26, which has grown by 1,752.13 percent. The net profit has also grown by 700 percent from Rs. 13 crore in Q3 FY25 to Rs. 104 crore in Q3 FY26.
In terms of return ratios, the company’s ROCE and ROE stand at 39.38 percent and 66.61 percent, respectively. Elitecon International Limited has an earnings per share (EPS) of Rs. 2.01, and its debt-to-equity ratio is 1.09x.
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
